ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

163 Episodo

1. ACCEL Lite: Behind the ACC 2021 Chest Pain Guidelines: Conversations That Shape Practice

   Publicado: 6/9/2022
2. ACCEL Lite: Selecting an Oral P2Y12 Inhibitor Post-MI: What’s the Best Choice?

   Publicado: 23/8/2022
3. ACCEL Lite: How Do I Implement the New 2022 ACC HF Guidelines Into My Practice?

   Publicado: 16/8/2022
4. ACCEL Lite: Evaluation of the Sudden Cardiac Arrest Survivor

   Publicado: 9/8/2022
5. ACCEL Lite: Top Takeaways from The ACC 2021 Chest Pain Guidelines for the Practicing Clinician

   Publicado: 2/8/2022
6. ACCEL Lite: Modern Managment of High-Risk PE

   Publicado: 26/7/2022
7. ACCEL Lite: Peripartum Cardiomyopathy: A Cardiologists Perspective

   Publicado: 19/7/2022
8. ACCEL Lite: Pre-Eclampsia: Maternal Red Flag of Risk

   Publicado: 14/7/2022
9. ACCEL Lite: Black Maternal Health: A Call to Action and Implications for Prevention

   Publicado: 13/7/2022
10. ACCEL Lite: ACC Expert Consensus Decision Pathway on COVID-19: Return to Play

    Publicado: 5/7/2022
11. ACCEL Lite: ACC Expert Consensus Decision Pathway on COVID-19: Post-acute Sequelae

    Publicado: 28/6/2022
12. ACCEL Lite: ACC Expert Consensus Decision Pathway on COVID-19: Myocarditis

    Publicado: 21/6/2022
13. ACCEL Lite: Inflamed! Populations at Risk for Inflammation Associated CVD

    Publicado: 14/6/2022
14. ACCEL Lite: Significant Updates from the 2021 ACC Coronary Artery Revascularization Guidelines

    Publicado: 7/6/2022
15. ACCEL Lite: ACC.22 Late Breaker: ADAPT-TAVR Trial - Edoxaban Versus DAPT For Valve Thrombosis And Cerebral TE After TAVR

    Publicado: 24/5/2022
16. ACCEL Lite: Late Breaker: APOLLO Trial - Magnitude And Duration Of Effects Of A Short-interfering RNA Targeting Lipoprotein(a)

    Publicado: 17/5/2022
17. ACCEL Lite: ACC.22 Late Breaker: CHAP RCT -- Antihypertensive Therapy For Mild Chronic Hypertension Improves Pregnancy Outcomes

    Publicado: 10/5/2022
18. ACCEL Lite: Late Breaker: APOLLO Trial - Magnitude And Duration Of Effects Of A Short-interfering RNA Targeting Lipoprotein(a)

    Publicado: 3/5/2022
19. ACCEL Lite: Late Breaker: Mavacamten as an Alternative To Surgical Septal Myectomy Or Alcohol Ablation In Patients With Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy

    Publicado: 26/4/2022
20. ACCEL Lite: Late Breaker: SODIUM-HF: Dietary Intervention Under 100 Mmol In Heart Failure

    Publicado: 19/4/2022